کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5502343 | 1400154 | 2017 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Should you screen nursing home residents for cancer?
ترجمه فارسی عنوان
آیا شما باید برای سرطان در خانه های پرستار خانه را ببینید؟
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
غربالگری سرطان، فرهیخته سالمند، مراقبت بلند مدت، وضعیت کارکردی، تصمیم گیری بالینی،
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
سالمندی
چکیده انگلیسی
When considering screening for early cancer detection physicians should anticipate how they plan to follow up a screen detected cancer. Geriatric oncology research has developed validated functional assessments to estimate the balance of risk and benefit for treating cancers in the elderly. Robust elderly can benefit from treatment and therefore might benefit from screening. However the majority of elderly in long term residential care (LTC, or “the nursing home”) would not benefit from cancer screening. The 1.4 million elderly people who reside in U.S. nursing homes represent the oldest and frailest segment of the aged population. On average, LTC residents have less than 5Â years estimated remaining life expectancy (RLE.) E.U. figures are similar. The majority have multiple functional deficits that would result in geriatric oncology screening scores in the frail range, at very high risk for severe toxicity from standard chemotherapy or extensive surgery. Therefore screening for asymptomatic cancer is not likely to benefit and has the potential to harm elderly nursing home residents.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Geriatric Oncology - Volume 8, Issue 3, May 2017, Pages 154-159
Journal: Journal of Geriatric Oncology - Volume 8, Issue 3, May 2017, Pages 154-159
نویسندگان
Miriam B. Rodin,